Research Articles

On September 7, the 13th National People’s Congress Standing Committee (NPCSC), China’s constitutional authority, released its...
China’s regulators recently released the first drug traceability proposal since China suspended its previous system in 2016...
The Shanghai Free Trade Zone (FTZ) Market Regulatory Authority (MRA) recently issued a penalty decision against a foreign...
China has implemented new rules setting requirements on the storage, use, and flow of scientific data. Although intended to...
US companies now have stronger recourse against Chinese businesses that claim Chinese law as a protection for unfair practices...
China’s National Development and Reform Commission (NDRC) recently announced its 2018 priorities for pricing investigations...
Chinese regulations on tendering and bidding practices published by the Ministry of Finance (MOF) in July are a promising sign...
Recently announced provincial reimbursement drug lists (PRDLs) provide possible new opportunities for US pharmaceutical...
Four new policies under development may address a variety of lingering regulatory hurdles for foreign drug and device companies...
This issue marks the first of a regular series of US-China Business Council (USCBC) reports analyzing key discussions and...
US and Chinese negotiators are gearing up for a busy quarter as they head into bilateral and multilateral trade and investment...
The United States and China wrapped up three days of commercial negotiations in Chicago yesterday, making  progress on...
As US and Chinese government officials prepare for a busy season of bilateral engagement—including the November meetings of the...
Recent food safety incidents in China have caused many foreign food and consumer goods companies to reexamine their quality...
As the US government prepares for upcoming negotiations at the Strategic and Economic Dialogue (S&ED) in early July,...
China’s long-awaited urbanization plan indicates that the country’s leaders will focus on increasing access to social services...
The US-China Business Council (USCBC) will recommend solutions to foreign investment, intellectual property, and administrative...
Bilateral engagement between the United States and China has begun to ramp up, with the US-China Business Council (USCBC)...
US and Chinese senior government officials announced movement on key business issues during this year’s plenary session of the...
During his trip to Asia earlier this month, Vice President Joseph Biden held a full day of meetings in China, marked by...
China’s National Development and Reform Commission (NDRC) has renewed its pledge to step up antimonopoly and price-fixing...
Despite complications created by last month’s US government shutdown, US and Chinese officials have concluded most remaining...
Expanding the size, efficiency, and diversity of China’s healthcare sector to meet growing consumer demand are key aims of...
US officials continued to push for the lowering of trade and investment barriers into China at the Joint Commission on Commerce...
The Chinese government’s recent investigations into GlaxoSmithKline (GSK) and other pharmaceutical companies have signaled...
Increasing insurance coverage, improving service in state-owned hospitals, and controlling healthcare prices were key...
Following months of speculation, the PRC National Development and Reform Commission (NDRC) and Ministry of Health (MOH) on...
China will soon release its long-awaited draft healthcare reform plan for public comment, said PRC Premier Wen Jiabao in his...
Medical and healthcare expenses are top concerns for the Chinese public and policymakers, according to a recent survey of...
China took more steps this week to address food and product safety concerns by introducing draft drug recall procedures, a new...

Pages